MoonLake Immunotherapeutics (MLTX)

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $1.36 billion. The enterprise value is $1.07 billion.

Market Cap	1.36B
Enterprise Value	1.07B

Important Dates

The last earnings date was Monday, May 11, 2026, before market open.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

MLTX has 72.85 million shares outstanding. The number of shares has increased by 5.48% in one year.

Current Share Class	72.85M
Shares Outstanding	72.85M
Shares Change (YoY)	+5.48%
Shares Change (QoQ)	+4.86%
Owned by Insiders (%)	9.76%
Owned by Institutions (%)	51.27%
Float	38.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.18
P/TBV Ratio	5.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.60, with a Debt / Equity ratio of 0.40.

Current Ratio	8.60
Quick Ratio	7.89
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28.15

Financial Efficiency

Return on equity (ROE) is -77.85% and return on invested capital (ROIC) is -39.65%.

Return on Equity (ROE)	-77.85%
Return on Assets (ROA)	-36.66%
Return on Invested Capital (ROIC)	-39.65%
Return on Capital Employed (ROCE)	-75.47%
Weighted Average Cost of Capital (WACC)	9.63%
Revenue Per Employee	n/a
Profits Per Employee	-$1.98M
Employee Count	130
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MLTX has paid $1.08 million in taxes.

Income Tax	1.08M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.17% in the last 52 weeks. The beta is 1.01, so MLTX's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	-53.17%
50-Day Moving Average	17.44
200-Day Moving Average	21.90
Relative Strength Index (RSI)	54.61
Average Volume (20 Days)	923,295

Short Selling Information

The latest short interest is 6.32 million, so 8.68% of the outstanding shares have been sold short.

Short Interest	6.32M
Short Previous Month	6.65M
Short % of Shares Out	8.68%
Short % of Float	16.27%
Short Ratio (days to cover)	5.22

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-267.37M
Pretax Income	-258.39M
Net Income	-257.08M
EBITDA	-264.48M
EBIT	-267.37M
Earnings Per Share (EPS)	-$3.87

Balance Sheet

The company has $357.92 million in cash and $100.80 million in debt, with a net cash position of $257.12 million or $3.53 per share.

Cash & Cash Equivalents	357.92M
Total Debt	100.80M
Net Cash	257.12M
Net Cash Per Share	$3.53
Equity (Book Value)	254.02M
Book Value Per Share	3.52
Working Capital	350.53M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	2.89M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.48%
Shareholder Yield	-5.48%
Earnings Yield	-19.36%
FCF Yield	n/a

Analyst Forecast

The average price target for MLTX is $27.62, which is 47.70% higher than the current price. The consensus rating is "Buy".

Price Target	$27.62
Price Target Difference	47.70%
Analyst Consensus	Buy
Analyst Count	15
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a